US pharma giant Pfizer on Friday revealed that the US Food and Drug Administration (FDA) has approved its Braftovi ...

In February 2024, the FDA approved Onivyde (irinotecan liposome) with oxaliplatin, fluorouracil and leucovorin for the ...

Adapted from reference 55. 7 ß-hCG level, CBC, LFTs, creatinine Repeat methotrexate if <15% decrease in ß-hCG level from day 4 Leucovorin ß-hCG level, CBC, LFTs, creatinine, Repeat methotrexate ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Pfizer Inc. (PFE) said that the U.S. Food and Drug Administration has approved BRAFTOVI (encorafenib) in combination with cetuximab ...

Consider folinic acid, otherwise known as leucovorin. It's one of the most common medicines prescribed for childhood leukemia ...

Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...

Consider folinic acid, otherwise known as leucovorin. It's one of the most common medicines prescribed for childhood leukemia ...